admission to a monitored setting
Rivaroxaban reversal
Bleeding secondary to other coagulopathy
Dabigatran reversal
Spontaneous bleeding
Warfarin reversal
Unfractionated heparin reversal
Anti-platelet agent reversal
Enoxaparin